IP Library Granted Patent US 7,625,720
Granted Patent B2
US 7,625,720 · App. 11/604,559 · Granted Dec 1, 2009

Nucleic acids encoding IL-174

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,625,720
App. No.
11/604,559
Granted
Dec 1, 2009
Kind
B2
Abstract

CTLA-8 related antigens from mammals, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said antigens. Methods of using said reagents and diagnostic kits are also provided.

Claims (11)

1. An isolated nucleic acid encoding an IL-174 polypeptide, wherein the polypeptide comprises SEQ ID NO:14 or amino acid residues 1-145 of SEQ ID NO:14.

2. The isolated nucleic acid of claim 1 , wherein the IL-174 polypeptide consists of SEQ ID NO:14 and the nucleic acid comprises nucleotides 19-501 of SEQ ID NO:13.

3. The isolated nucleic acid of claim 2 , which is an expression vector.

4. The isolated nucleic acid of claim 1 , which is an expression vector.

5. An isolated cell containing the expression vector of claim 4 .

6. The isolated cell of claim 5 , wherein the encoding nucleic acid comprises nucleotides 19-501 of SEQ ID NO:13.

7. The isolated cell of claim 5 , which is a prokaryotic cell.

8. The isolated cell of claim 5 , which is a eukaryotic cell.

9. The isolated cell of claim 8 , which is a mammalian cell.

10. A method of making an IL-174 polypeptide comprising expressing the expression vector of claim 4 , thereby producing the IL-174 polypeptide.

11. The method of claim 10 , wherein the IL-174 polypeptide consists of SEQ ID NO:14 and the expression vector comprises nucleotides 19-501 of SEQ ID NO:13.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →